1001 NORTH US HWY 1, JUPITER, FL
Announces Pricing of $2.0 Million Registered Direct Offering
Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech
Material disclosure
Jupiter Neurosciences Enters $6 Million Standby Equity Purchase Agreement
Jupiter Neurosciences Enters Standby Equity Purchase Agreement
Jupiter Neurosciences Approves 2025 Equity Incentive Plan at Annual Meeting
Amended material disclosure
Annual Report to Security Holders
Q1
Notice of Late Filing for Annual Report
FY 2025
Q3
Q2
Notice of Late Filing for Quarterly Report
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRER14A
PRE 14A
Statement of Changes in Beneficial Ownership
No filings found